MobiHealth News October 1, 2020
Mallory Hackett

Valo Health’s Opal Computational Platform uses machine learning, cloud computing and real-world data to assist in the drug discovery and development process.

Flagship Pioneering recently launched its latest company, Valo Health, which has a drug-discovery technology platform.

Valo’s Opal Computational Platform uses machine learning, cloud computing and real-world data to assist in the drug-discovery and development process. It is currently focusing on treatments for cardiovascular diseases, neurodegeneration and cancer.

The platform works by first identifying drug candidates for a certain disease. From there, it evaluates both new and known molecules to estimate how they will react within the body while predicting which patients will see the best results. Additionally, Opal can design the clinical trials needed to test its hypotheses.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Cloud, Pharma, Pharma / Biotech, Technology
How Will Walgreens’ Expansion into Specialty Pharmacy Affect the Industry?
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Fierce Biotech Layoff Tracker 2024: BMS to cut 2K+ roles; Tessera trims workforce in shift to clinic
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise?
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture

Share This Article